Magdy Shenouda Selected Research

2-hydroxydesipramine

2/2009

The effects of desvenlafaxine and paroxetine on the pharmacokinetics of the cytochrome P450 2D6 substrate desipramine in healthy adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magdy Shenouda Research Topics

Disease

1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2014
1	Hyperglycemia 05/2014
1	Acromegaly 05/2014
1	Pituitary ACTH Hypersecretion 05/2014
1	Neoplasms (Cancer) 05/2014
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2014
1	Memory Disorders (Memory Loss) 07/2013
1	Alzheimer Disease (Alzheimer's Disease) 07/2013
1	Hemophilia A (Haemophilia) 10/2011
1	Hemorrhage 10/2011
1	Major Depressive Disorder (Major Depressive Disorders) 02/2009

Drug/Important Bio-Agent (IBA)

1	Glucagon (Glukagon)FDA Link 05/2014
1	Somatostatin Receptors (Somatostatin Receptor)IBA 05/2014
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2014
1	pasireotideIBA 05/2014
1	1- (3',4'- dichloro- 2- fluoro(1,1'- biphenyl)- 4- yl)cyclopropanecarboxylic acidIBA 07/2013
1	Amyloid (Amyloid Fibrils)IBA 07/2013
1	recombinant FVIIa (rFVIIa)FDA Link 10/2011
1	Clopidogrel (Plavix)FDA Link 10/2011
1	IsoantibodiesIBA 10/2011
1	Paroxetine (Paxil)FDA LinkGeneric 02/2009
1	2-hydroxydesipramineIBA 02/2009
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 02/2009
1	Desvenlafaxine Succinate FDA Link 02/2009

Therapy/Procedure

1	Therapeutics 10/2011